Stocks / HROW vs LXRX

Harrow, Inc. (HROW) vs Lexicon Pharmaceuticals, Inc. (LXRX)

Harrow, Inc. and Lexicon Pharmaceuticals, Inc. side by side — fundamentals from SEC filings, refreshed nightly. Sector: Healthcare.

HROW is the larger company ($1.4B vs $0.8B). On the fundamentals, HROW grows revenue faster (41.0% vs 15.7%); HROW earns a higher net margin (-1.9% vs -101.1%); HROW has the stronger return on equity (-9.8% vs -46.8%). Over the last five years, HROW returned 298.3% vs -59.0%. Both carry 3 potential red flags in the filings. Full numbers below — the stronger figure on each row is in green.

AI verdict — HROW vs LXRX, read from the filings

The stronger business, the cheaper stock, and the risks — synthesised from both companies’ SEC filings, every figure computed not guessed. Not investment advice.

	Harrow, Inc. (HROW)	Lexicon Pharmaceuticals, Inc. (LXRX)
Market cap	$1.4B	$0.8B
Revenue (latest FY)	$272.30M	$49.80M
Net income (latest FY)	$-5.14M	$-50.34M
Revenue growth (5y CAGR)	41.0%	15.7%
Net margin	-1.9%	-101.1%
Return on equity	-9.8%	-46.8%
P/E ratio	—	—
Dividend yield	—	—
Profitable years (of last 10)	2	1
Positive free cash flow	Yes	No

Performance — HROW vs LXRX

Total returns from monthly split- and dividend-adjusted closes; 52-week range from the latest quote. Past performance is not a prediction.

	Harrow, Inc. (HROW)	Lexicon Pharmaceuticals, Inc. (LXRX)
1-year return	21.2%	97.9%
3-year return	94.3%	-17.9%
5-year return	298.3%	-59.0%
10-year return	884.0%	-86.9%
52-week range	$28.54–$54.85	$0.64–$2.53

Verify the comparison

Check earnings versus cash flow →Compare filed share counts →Open the latest SEC filing timeline →Run another company comparison →

Use the filing period and source shown by each tool before treating two figures as comparable.

Compare with another company:

See the full HROW vs LXRX breakdown

Both companies across 19 years of income statement, balance sheet and cash flow — with ratios, health checks and Ask, the SEC-grounded research assistant. Free, no account needed.

Open HROW's full financials → Open LXRX's full financials →

More comparisons

HROW vs URGN AHCO vs LXRX ATAI vs HROW LXRX vs MAZE HROW vs VIR BCAX vs LXRX BCAX vs HROW LXRX vs URGN

Frequently asked questions

Which is bigger, HROW or LXRX?

Harrow, Inc. is larger by market capitalization — $1.4B versus $0.8B.

Which grows faster, HROW or LXRX?

Over the last five fiscal years, Harrow, Inc. grew revenue faster — 41.0%/yr versus 15.7%/yr, computed from SEC-filed statements.

Where does this data come from?

All figures are computed from official SEC filings (10-K), refreshed nightly. This is a data comparison, not investment advice.

Keep exploring

Fastest-growing stocks →

HROW fundamentals → · LXRX fundamentals → · All 1,500+ companies → · Free screener →